Figure 2
Figure 2. Ligand binding by soluble, rGPVI isoforms. An ELISA was used to measure the binding of rsGPVIa (●) or rsGPVIb (○) to microtiter plates coated with type I collagen (A), CRP (B), CVX (C) or bovine serum albumin (data not shown). rsGPVIa or rsGPVIb was added at a final concentration of 0.5, 1, 2, 5, or 10 μg/mL (abscissa), and the plates were incubated for 90 minutes at 37°C. Unbound rsGPVI was removed, and bound rsGPVI was quantitated by addition of HRP-conjugated anti-FLAG antibody. The amount of bound antibody was determined in a colorimetric reaction, reading absorbance at 490 nm (ordinate). Each data point represents the mean ± SD for n ≥ 3. The binding of either rsGPVIa or rsGPVIb to bovine serum albumin was virtually nil (data not shown).

Ligand binding by soluble, rGPVI isoforms. An ELISA was used to measure the binding of rsGPVIa (●) or rsGPVIb (○) to microtiter plates coated with type I collagen (A), CRP (B), CVX (C) or bovine serum albumin (data not shown). rsGPVIa or rsGPVIb was added at a final concentration of 0.5, 1, 2, 5, or 10 μg/mL (abscissa), and the plates were incubated for 90 minutes at 37°C. Unbound rsGPVI was removed, and bound rsGPVI was quantitated by addition of HRP-conjugated anti-FLAG antibody. The amount of bound antibody was determined in a colorimetric reaction, reading absorbance at 490 nm (ordinate). Each data point represents the mean ± SD for n ≥ 3. The binding of either rsGPVIa or rsGPVIb to bovine serum albumin was virtually nil (data not shown).

Close Modal

or Create an Account

Close Modal
Close Modal